Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Model Portfolio Of 16 Top-Quality Stocks From SPA



SPA has identified 16 stocks which they claim will deliver out-sized gains to investors




The stocks are chosen across diverse sectors. They include small-caps, mid-caps and large caps. A detailed rationale in support of each stock is also given.

Click here to download the Model Portfolio of 16 top-quality stocks
Large Cap, Mid Cap, Multibagger, Portfolio, Small Cap, Top Picks    , ,

2 Comments
  1. Avishek's Gravatar Avishek
    November 25, 2014 at 9:42 pm | Permalink

    Is these stocks are really top quality stocks? I have found several junks in this list.

    Reply
  2. ROHIT's Gravatar ROHIT
    November 27, 2014 at 4:31 pm | Permalink

    I really dont think these are 16 top quality stocks. The researcher seems to have got it totally wrong.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 493 other subscribers

RSS Stocks Talk Forum

  • Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap)
    Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap) for Nov '24. The Basket has delivered return of 329% since inception (May’20) vs 162% return delivered by NIFTY Index over the same period due to thematic approach to Top Picks selection Download report
  • Shalby is a multi-specialty hospital chain with expertise in joint replacement
    Shalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
  • DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
    DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!